Welcome to HitGen
CN EN

News

Get up to date with the latest HitGen articles and join us in the events

News
Press Release
Coverage
Events
Industry News
  2. News
  3. Press Release

OpenDEL®5.0限时优惠启动！40亿化合物库（38亿小分子+2亿肽类化合物）助力新分子药物发现

Thanks for reading!

For more details on how we can advance your innovative drug discovery projects
验证码
By submitting your information, you acknowledge having received, read and understood our Privacy Notice as made available above.
Sites

HitGen Inc.

Building C2, NO.8, Huigu 1st East Road
Tianfu International Bio-Town,
Shuangliu District, Chengdu City,
Sichuan Province,P.R. China

Tel : +86-28-8519-7385

HitGen Pharmaceuticals Inc.(US Subsidiary)

Tel : +1-(508)-840-9646

Vernalis (R&D) Limited (UK Subsidiary)

Granta Park,Great Abington
Cambridge,CB21 6GB
United Kingdom

Tel : +44(0)1223-895555

Quick Links
About
Capabilities
Service
Therapeutic Areas
Pipeline
News
Investors
Careers
Contact
Business Inquiry : bd@hitgen.com
Investor Relations : investors@hitgen.com
Media : media@hitgen.com
Career and Jobs : human.resources@hitgen.com

Newsletter
Follow Us :
© 2021 HitGen Inc. All Rights Reserved. 蜀ICP备16024889-1号 川公网安备 51012202000492号
Terms of Use 丨 Privacy Policy

We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for More information

↑